共 50 条
[41]
Can proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors regress coronary atherosclerotic plaque? A systematic review and meta-analysis
[J].
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH,
2023, 15 (01)
:452-465